1Dubinsky RM, Kabbani H, E1-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2004, 63(6): 959-965.
4Wang S, Lim G, Yang L, et al. Downregulation of spinal glutamate transporter EAAC1 following nerve injury is regulated by central glucocorticoid receptors in rats[J]. Pain, 2006, 120( 1- 2): 78-85.
4Wallace MS,Irving G,Cowles VE.Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia:a randomized,double-blind,placebo-controlled,multicentre study.Clin Drug Investig,2010,30(11):765-776.
5HOARE S R,SULLIVAN S K,PAHUJA A,et al.Conformational states of the corticotropin releasing factor 1 (CRF1) receptor:detection,and pharmacological evaluation by peptide ligands[J].Peptides,2003,24(12):1881 -1897.
6ABBORT F V,FRANKLIN K B,WESTBROOK R F.The formalin test:scoring properties of the first and second phases of the pain response in rats[J].Pain,1995,60(1):91 -102.
7WANG W,JI P,RIOPELLE R J,et al.Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia[J].J Neurochem,2002,80 (2):287 -294.
8MCLOON L K,SANDNAS A M,NOCKLEBY K J,et al.Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of corticotropin releasing factor in rabbit eyelid[J].Inflamm Res,2002,51(1):16-23.
9MELZACK R,WALL P D.The challenge of pain[M].Updated 2nd ed.London:Penguin Books,1996; 339.
10SUN W Z,SHYU B C,SHIEH J Y.Nitrous oxide or halothane,or both,fail to suppress c-fos expression in rat spinal cord dorsal horn neurones after subcutaneous formalin[J].Br J Anaesth,1996,76(1):99 -105.
